1. Academic Validation
  2. Golgi-Targeted Fluorescent Probe for Imaging NO in Alzheimer's Disease

Golgi-Targeted Fluorescent Probe for Imaging NO in Alzheimer's Disease

  • Anal Chem. 2022 Jul 19;94(28):10256-10262. doi: 10.1021/acs.analchem.2c01885.
Zixu He 1 2 Diankai Liu 1 Ya Liu 1 Xiaohua Li 1 Wen Shi 1 2 Huimin Ma 1 2
Affiliations

Affiliations

  • 1 Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
  • 2 University of Chinese Academy of Sciences, Beijing 100049, China.
Abstract

Nitric oxide (NO) is a crucial neurotransmitter participating in many biological processes via nitrosylation reaction. NO produced in diverse subcellular regions also regulates the function of cells in different manners. A Golgi apparatus is rich in nitric oxide synthase and may serve as a potential therapeutic target for Alzheimer's disease (AD). However, due to the lack of an effective tool, it is difficult to reveal the relationship between Golgi-NO and AD. Herein, we report Golgi-NO as the first Golgi-targeted fluorescent probe for sensing and imaging NO in the Golgi apparatus. The probe is designed and synthesized by incorporating 4-sulfamoylphenylamide as a Golgi-targeted moiety to 6-carboxyrhodamine B, generating a fluorophore of Golgi-RhB with modifiable carboxyl, which is then combined with the NO recognition moiety of o-diaminobenzene. The probe shows superior analytical performance including accurate Golgi-targeted ability and high selectivity for NO. Moreover, using the probe, we disclose a significant increase of NO in Golgi apparatus in the AD model. This study provides a competent tool for studying the function and nitrosylation of NO in the Golgi apparatus in related diseases.

Figures
Products